The effect of the cognitive function and cerebral white matter lesions of pitavastatin in hypercholesterolemic patients with cognitive dysfunction.
Not Applicable
- Conditions
- Hypercholesterolemic patients with cognitive dysfunction
- Registration Number
- JPRN-UMIN000013231
- Lead Sponsor
- Department of Geriatric Medicine, Kyorin University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.History of hypersensitivity to any of the ingredients of the product. 2.Severe hepatic disorder or biliary atresia. 3.Receiving cyclosporine. 4.Patients receiving fibrates who also have laboratory evidence of abnormal renal function. 5.Individuals who are ineligible in the opinion of the physician in charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method .Change of cerebral white matter lesions(MRI) .Change of arteriosclerosis marker(PWV, IMT) .Change of cognitive function(MMSE) .Change of cerebral blood flow(SPECT) .Change of serum lipids
- Secondary Outcome Measures
Name Time Method